top of page

2021 Articles

Volume 3 Issue 1

Towards Consilience Between Research Paradigms and Spiritual Practice

Thomas D. Meacham, M.D.

Volume 3 Issue 1

Letter To The Editor

Megan Oxley, M.D.

Volume 3 Issue 1

Letter To The Editor

Scott Allen, M.D.; Rachel Allen, M.D.

Volume 3 Issue 1

Ayahuasca Tea in the United States: Why and how?

LJ Standish N.D., PhD; Juan Giménez Ph.D.; and Victoria G Hale, Ph.D.

Volume 3 Issue 2

Synthetic Cannabinoid-Induced Compulsive Sexual Behaviors: A Case Report

Amanda Klass, D.O.

Volume 3 Issue 2

A Comprehensive Review of Potential Uses of Ayahuasca in Psychiatry

Adam Bertroche, D.O.

Volume 3 Issue 2

Is Psychedelic Therapy Integrative Medicine?

Matthew Hicks, N.D., M.S.

Volume 3 Issue 2

Editorial Review: Trial of Psilocybin versus Escitalopram for Depression

Gershom Hernandez, M.D.

Volume 3 Issue 3

Psychedelics and Response Duration

Gregory Jones, M.D.; Hunter Hinman M.D.; Elizabeth Mays M.D.; Daniel Liaou M.D.

Volume 3 Issue 3

Newspaper Coverage of Psilocybin – Sentiment and Frequency (1989-2020)

Dax Oliver, M.A.

Volume 3 Issue 3

Practical and Ethical Considerations for Psychedelic Therapy and Integration Practices

Ismail Lourido Ali, J.D., Geoff Bathje, Ph.D., Roxanne R. Hallisey, B.S., Leslie Booher, J.D., M.B.A., Brooke Novick, L.M.F.T., Allison Feduccia, Ph.D.

Volume 3 Issue 4

Psilocybin as an Abortive Treatment for Intractable Migraines: A Case Report

Alicia McCullough, M.D.

Volume 3 Issue 4

Successful Self-Medication of a Major Depressive Episode with Repeated Administration of LSD: A Case Report

Jennifer Lyke, Ph.D. and Trey Brasher, B.S.

Volume 3 Issue 4

Internal Family Systems: A Therapeutic Model for Each Stage of the Psychedelic Experience

Nancy L. Morgan, Ph.D., Patrycja Radecka, Pg.Dip., and Coen de Koning, B.Sc.

bottom of page